Novel orally bioavailable EZH1/2 dual inhibitors with greater antitumor efficacy than an EZH2 selective inhibitor
暂无分享，去创建一个
T. Horiuchi | M. Hirasawa | T. Takizawa | Tomonori Yamasaki | I. Yasumatsu | A. Nakao | Junzo Kinoshita | D. Honma | O. Kanno | E. Nosaka | Keisuke Suzuki | K. Nakajima | M. Hayakawa | Nobuaki Adachi | Jun Watanabe | M. Shiroishi | Takanori Yamazaki | A. Yadav | Daisuke Honma